Article

Intranasal Administration of ACIS KEPTIDEâ„¢ Prevents SARS-CoV2-Induced Acute Toxicity in…

bioRxiv: the preprint server for biology · 2020 · Gunnar Gottschalk, author James F Keating, author Kris Kesler, author Konstance Knox, author Avik Roy, author

Key facts

Title Intranasal Administration of ACIS KEPTIDEâ„¢ Prevents SARS-CoV2-Induced Acute Toxicity in K18-hACE2 Humanized Mouse Model of COVID-19: A Mechanistic Insight for the Prophylactic Role of KEPTIDEâ„¢ in COVID-19
First author Gunnar Gottschalk, author James F Keating, author Kris Kesler, author Konstance Knox, author Avik Roy, author
Journal bioRxiv : the preprint server for biology
Published Nov 18, 2020
DOI 10.1101/2020.11.13.378257
Devices mentioned 202002

At a glance

  • 1–9 FDA submissions mentioned
  • None Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature